Literature DB >> 19797282

Recurrence of bile salt export pump deficiency after liver transplantation.

Paloma Jara1, Loreto Hierro, Pilar Martínez-Fernández, Rita Alvarez-Doforno, Francisca Yánez, María C Diaz, Carmen Camarena, Angela De la Vega, Esteban Frauca, Gema Muñoz-Bartolo, Manuel López-Santamaría, Javier Larrauri, Luis Alvarez.   

Abstract

Severe bile salt export pump (BSEP) deficiency is a hereditary cholestatic condition that starts in infancy and leads to end-stage liver disease. Three children who underwent orthotopic liver transplantation for severe BSEP deficiency had post-transplantation episodes of cholestatic dysfunction that mimicked the original disease. Remission of all episodes was achieved by intensifying the immunosuppressive regimen. The phenotypic recurrence of the disease correlated with the presence of circulating high-titer antibodies against BSEP that inhibit transport by BSEP in vitro. When administered to rats, these antibodies targeted the bile canaliculi and impaired bile acid secretion. 2009 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797282     DOI: 10.1056/NEJMoa0901075

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  21 in total

1.  Clinical utility gene card for: progressive familial intrahepatic cholestasis type 2.

Authors:  Emmanuel Gonzales; Anne Spraul; Emmanuel Jacquemin
Journal:  Eur J Hum Genet       Date:  2013-08-28       Impact factor: 4.246

Review 2.  Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.

Authors:  Ashley Mehl; Humberto Bohorquez; Maria-Stella Serrano; Gretchen Galliano; Trevor W Reichman
Journal:  World J Transplant       Date:  2016-06-24

3.  Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI.

Authors:  Rosa Chan; Leslie Z Benet
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

Review 4.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

Review 5.  Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.

Authors:  Ralf Kubitz; Carola Dröge; Stefanie Kluge; Claudia Stross; Nathalie Walter; Verena Keitel; Dieter Häussinger; Jan Stindt
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 6.  Cholestatic liver disease in children.

Authors:  Jorge L Santos; Monique Choquette; Jorge A Bezerra
Journal:  Curr Gastroenterol Rep       Date:  2010-02

Review 7.  Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.

Authors:  Kazuo Imagawa; Hisamitsu Hayashi; Yusuke Sabu; Ken Tanikawa; Jun Fujishiro; Daigo Kajikawa; Hiroki Wada; Toyoichiro Kudo; Masayoshi Kage; Hiroyuki Kusuhara; Ryo Sumazaki
Journal:  J Hum Genet       Date:  2018-03-05       Impact factor: 3.172

8.  Paediatric cholestatic liver disorders for the adult gastroenterologist: a practical guide.

Authors:  Claire Kelly; Jeremy Shanika Nayagam; Stamatina Vogli; Marianne Samyn; Deepak Joshi
Journal:  Frontline Gastroenterol       Date:  2020-08-03

Review 9.  Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.

Authors:  Carol J Soroka; James L Boyer
Journal:  Mol Aspects Med       Date:  2013-05-15

Review 10.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.